Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Plus Therapeutics (PSTV) Preferred Dividend Payments (2017 - 2019)

Plus Therapeutics (PSTV) has disclosed Preferred Dividend Payments for 5 consecutive years, with $554000.0 as the latest value for Q3 2019.

  • Quarterly Preferred Dividend Payments fell 77.72% to $554000.0 in Q3 2019 from the year-ago period, while the trailing twelve-month figure was $3.0 million through Dec 2019, down 52.95% year-over-year, with the annual reading at $554000.0 for FY2019, 77.72% down from the prior year.
  • Preferred Dividend Payments for Q3 2019 was $554000.0 at Plus Therapeutics, down from $2.5 million in the prior quarter.
  • The five-year high for Preferred Dividend Payments was $4.0 million in Q4 2017, with the low at $554000.0 in Q3 2019.
  • Average Preferred Dividend Payments over 4 years is $1.9 million, with a median of $1.6 million recorded in 2015.
  • Peak annual rise in Preferred Dividend Payments hit 77.72% in 2019, while the deepest fall reached 77.72% in 2019.
  • Over 4 years, Preferred Dividend Payments stood at $661000.0 in 2015, then soared by 501.66% to $4.0 million in 2017, then plummeted by 37.47% to $2.5 million in 2018, then plummeted by 77.72% to $554000.0 in 2019.
  • According to Business Quant data, Preferred Dividend Payments over the past three periods came in at $554000.0, $2.5 million, and $4.0 million for Q3 2019, Q3 2018, and Q4 2017 respectively.